Swiss National Bank Invests $1 Million in Biotech Firm Monte Rosa Therapeutics
The Swiss National Bank has made an investment of $1 million in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE), as per its recent filing with the Securities and Exchange Commission.
The bank purchased a total of 61,100 shares of the company's stock in the first quarter, valued at approximately $1,005,000.
This investment accounts for about 0.07% of Monte Rosa Therapeutics' outstanding shares at the end of the most recent reporting period.